XSpray Pharma AB (XSPRAY) — Cash Flow Reinvestment Rate
Latest as of September 2017:
138.93x
XSpray Pharma AB (XSPRAY) has a Cash Flow Reinvestment Rate of 138.93x as of September 2017, reinvesting Skr6.39 Million (capex Skr6.39 Million ) from operating cash flow of Skr46.00K. Explore capital reinvestment ratio of XSpray Pharma AB to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
138.93x
(Capex + Investments) / Operating CF
Total Reinvested
Skr6.39 Million
Capex + Investments
Operating Cash Flow
Skr46.00K
SEK
Capital Expenditures
Skr6.39 Million
SEK
Annual Cash Flow Reinvestment Rate for XSpray Pharma AB (None–None)
Year-by-year capital reinvestment analysis for XSpray Pharma AB. For live market cap and broader valuation context, see XSPRAY market cap.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow